Mimecan/OIF Antibody [Alexa Fluor® 350]

• Reactivity: Mu
• Applications: WB
• Clonality: Polyclonal
• Host: Goat
• Conjugate: Alexa Fluor 350

Mimecan/OIF Antibody [Alexa Fluor® 350] Summary

• Immunogen: Mouse myeloma cell line NS0-derived recombinant mouse Mimecan
  Ala20-Phe298
  Accession # Q62000
• Specificity: Detects mouse Mimecan in direct ELISAs and Western blots. In direct ELISAs, approximately 10% cross-reactivity with recombinant human Mimecan is observed.
• Isotype: IgG
• Clonality: Polyclonal
• Host: Goat
• Purity Statement: Antigen Affinity-purified

Applications/Dilutions

• Dilutions:
  • Western Blot

Packaging, Storage & Formulations

• Storage: Protect from light. Do not freeze. 12 months from date of receipt, 2 to 8 °C as supplied
• Buffer: Supplied 0.2mg/ml in 1X PBS with RDF1 and 0.09% Sodium Azide

Notes

This product is produced by and ships from R&D Systems, Inc., a Bio-Techne brand.

Alternate Names for Mimecan/OIF Antibody [Alexa Fluor® 350]

• DKFZp586P2421
• KSPG25
• mimecan proteoglycan
• Mimecan
• OGN
• OIF
• OIFOG
• osteoglycin (osteoinductive factor)
• osteoglycin
• Osteoinductive factor
• SLRR3A
• SLRR3Acorneal keratan sulfate proteoglycan

Background

Mimecan, also known as KSPG25 (25 kDa Keratan Sulfate Proteoglycan) and Osteoglycin, is an extracellular matrix protein belonging to the class III subfamily of the small leucine rich proteoglycan (SLRP) family. SLRPs are characterized by leucine rich repeats in the central domain, which is flanked by N- and C-terminal cysteine‑rich domains. The core proteins contain N-linked oligosaccharides as well as glycosaminoglycan side chains. Mimecan is synthesized as a preproprotein that is processed to generate proteins of different sizes including Osteoglycin (containing 93 most C‑terminal amino acid residues) and Mimecan (containing 223 most C‑terminal residues). Mouse Mimecan shares approximately 94% and 85% amino acid sequence identity with rat and human Mimecan, respectively.

Limitations

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.